Man­u­fac­tur­ing roundup: Actylis opens the doors to a fa­cil­i­ty in Ore­gon; Emer­gent re­ports Q4 num­bers

The in­gre­di­ents man­u­fac­tur­er Actylis has opened a new 30,000-square-foot fa­cil­i­ty in the city of Eu­gene, OR.

Actylis CEO Gilles Cot­ti­er said in a state­ment the new site will al­low the com­pa­ny to man­u­fac­ture APIs and in­ter­me­di­ates for clin­i­cal tri­als — and on a com­mer­cial scale.

“We de­signed this fa­cil­i­ty specif­i­cal­ly to en­able us to de­vel­op and pro­duce in­no­v­a­tive APIs for our cus­tomers. Our in­ti­mate knowl­edge of their needs, our con­sul­ta­tive ap­proach, and our fo­cus on in­no­va­tion of­fer un­par­al­leled choice and flex­i­bil­i­ty,” Cot­ti­er added.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN